Scientists have concluded a Phase 3 trial of a revolutionary gene therapy treating patients with a common form of mitochondrial blindness, and the results surprised them despite treating only one eye, the gene therapy improved vision in both eyes in 78% of participants. The results suggest the treatment is incredibly promising for a condition in which most legally-blind patients would never recover their vision.
Conducted on 37 patients with Leber hereditary optic neuropathy (LHON), the trial involved a gene therapy using a virus vector to modify genes within the patients retinal cells. The results were published in the journal Science Translational Medicine.
LHON affects around 1 in every 50,000 people, with some patients experiencing significant vision loss in a matter of weeks. People affected by the disease will likely lose vision in one eye before subsequent vision loss in the other within 2-3 months. Treatments are limited to visual aids and attempted rehabilitation but have limited success. Typically, just 20% of patients will recover vision and it is extremely rare to recover vision greater than the worst score possible on a standard eye chart (20/200).
As someone who treats these young patients, I get very frustrated about the lack of effective therapies, said senior investigator Dr Sahel, a professor of ophthalmology at the University of Pittsburgh, in a statement.
These patients rapidly lose vision in the course of a few weeks to a couple of months. Our study provides a big hope for treating this blinding disease in young adults.
The treatment aims at correcting a common mutation within the MT-ND4 gene. MT-ND4 is a core subunit in a protein associated with mitochondria, and a mutation marked m. 11778G>A is thought to be associated with blinding neuropathy. Similarly, mutations in MT-ND4 may also be related to several other brain conditions, although these are not the same as the mutation targeted in this study.
37 patients were injected with the adenovirus-based therapy in one eye and a sham injection (a placebo or, in this case, fake injection) into the other. The trial was randomized and double-blind across multiple centres, which make it the gold-standard of clinical trials. After 48 and 96 weeks, the participants were tested for vision changes and whether they showed signs of improvement using a standard Snellen eye chart (the ones with rows of smaller and smaller letters).
The researchers found that, on average, vision was improved by 15 letters (3 lines on the chart) after 96 weeks, which is an extremely impressive result. However, to the surprise of the researchers, the sham-treated eyes also saw an average improvement of 13 letters. Those that were in the early stages of disease and still losing their vision when they joined the study saw an even better improvement, being able to see 28.5 letters more in the treated eyes on average.
We expected vision to improve in the eyes treated with the gene therapy vector only. Rather unexpectedly, both eyes improved for 78% of patients in the trial following the same trajectory over 2 years of follow-up. Said Dr Yu-Wai-Man, neuro-ophthalmologist at CambridgesDepartment of Clinical Neuroscience.
To decipher how this treatment improved both eyes, the researchers conducted a subsequent study on primates. After injection in the same way as the study above, they found the viral vector was present in cells throughout the eye that was not treated, although the mechanism in which this occurs needs confirmation.The researchers suggest that the viral vector may have transferred across neurones via interocular diffusion, and hence there was an improvement in vision in both eyes.
The results suggest an extremely promising new treatment for a rare but debilitating form of blindness. Further trials are expected to take place to confirm the results, and there are some outstanding limitations of the trial. For example, there was not a control group with this exact mutation, so the researchers could not directly compare to the treatment.
Saving sight with gene therapy is now a reality. The treatment has been shown to be safe and we are currently exploring the optimal therapeutic window. Said Dr Yu-Wai-Man.
Read the rest here:
Gene Therapy Unexpectedly Improves Vision In Both Eyes Of Patients Suffering A Form Of Blindness - IFLScience
- 10 Daily Habits That Will Help You Protect Your Eye Health - CNET - January 25th, 2024
- Undergoing cataract surgery when it's not necessary? Some do it to improve their eyesight, but it's not without risk - The Conversation Indonesia - January 25th, 2024
- Sight Care Reviews - Is It Safe to Use? The Most Important Fact to Know Before Buy! - Kent Reporter - January 25th, 2024
- Apple has big and cartoonish plans for Vision Pro's EyeSight - AppleInsider - January 25th, 2024
- National Center for Children's Vision and Eye Health at Prevent Blindness Celebrates 15th Anniversary in 2024 - PR Web - January 25th, 2024
- Understanding Computer Vision Syndrome: Causes, Symptoms, and Practical Solutions - Medriva - January 25th, 2024
- 8 Eye Issues You Should Never Ignore - Right as Rain by UW Medicine - January 9th, 2024
- Digital eye strain is a growing issue as the muscles of the eyes work overtime, warn vision experts - Fox News - January 9th, 2024
- Know the Facts About Glaucoma - MedicineNet - January 9th, 2024
- New Year, New Vision: Top Resolutions For Optimal Eye Health - ABP Live - January 9th, 2024
- Childhood Myopia and Its Impact on Vision Loss: What Causes It? - News18 - January 9th, 2024
- What you see first in optical illusion can reveal a lot about you but youll need 20/20 vision to spot hi... - The Sun - January 9th, 2024
- The Importance of Eye Care: Preventing Vision Impairments and Maintaining Good Eye Health - Medriva - December 30th, 2023
- Six ways to look after your eyes in 2024 - The Conversation - December 30th, 2023
- 6 Essential Ways to Safeguard and Improve Your Vision in 2024 - Medriva - December 30th, 2023
- SightCare Reviews - Obvious Hoax or Safe Pills That Work? Fake Scams to Avoid | Courier-Herald - Enumclaw Courier-Herald - December 30th, 2023
- SightCare Reviews - Honest Customer Warning! Real Eyesight Support or Fake Hype? - Bothell-Kenmore Reporter - December 30th, 2023
- Global Intraocular Lens Market Surges with Innovations in Vision Correction | CAGR of 5.6% - PharmiWeb.com - December 30th, 2023
- Infection of the eye, and how to protect vision - The Hindu - December 30th, 2023
- Optical Illusion Eye Test: Can you find the dog in the street in 7 seconds? - Jagran Josh - December 30th, 2023
- You have 20/20 vision if you can find the hidden chick amongst these ducks - IndiaTimes - December 30th, 2023
- Eye Doc: Look *Here* While You Drive + 8 More Genius Tips to Improve Night Vision Behind The Wheel - Yahoo Life - December 22nd, 2023
- Designer creates inclusive clothing company after losing eyesight - Fox Business - December 22nd, 2023
- What is the state of American eyesight? - USAFacts - December 22nd, 2023
- When temporary vision loss in one eye isn't a sign of stroke - Harvard Health - December 22nd, 2023
- 10 Hacks That Can Naturally Boost Your Eye Health Today - CNET - December 22nd, 2023
- SightCare Reviews (Critical Customer Warning!) Know The Sight Care Facts Before Buy - Ukiah Daily Journal - December 22nd, 2023
- Everyone can spot the building with the hole in it but only those with 20/20 vision can find the giant C... - The US Sun - December 22nd, 2023
- Flashes, shimmers and blind spots: Here's what migraine aura looks like - The Washington Post - December 22nd, 2023
- Doctors Reveal the Snack That Cuts Your Risk of Vision-Clouding Cataracts in Half - Yahoo Life - December 22nd, 2023
- Yoga For Healthy Vision: 5 Extraordinary Yogasanas To Improve Eyesight - Netmeds.com - December 22nd, 2023
- Everyone can spot the teddy bears but you have 20/20 vision if you can see the bee in the bedroom in under... - The US Sun - December 22nd, 2023
- Reindeers blue eyes act as night vision goggles to help them find food in winter - The Guardian - December 22nd, 2023
- 6 Bad Habits That Could Be Damaging Your Eyesight - Money Talks News - December 22nd, 2023
- Reindeer vision may have evolved to spot favorite food in the snowy dark of winter - Phys.org - December 22nd, 2023
- Human eyes: How they work, and their amazing anatomy - BBC Science Focus Magazine - December 22nd, 2023
- Why reindeer eyes shine blue in the winter - The Washington Post - December 22nd, 2023
- Can Everyone Unfocus Their Eyes On Command? - IFLScience - December 22nd, 2023
- You have the eyes of a hunter if you can spot the dogs owner in the picture in 8 seconds! - Jagran Josh - December 22nd, 2023
- Everyone can see the Christmas trees but you could have 20/20 vision if you can spot the star hiding in t... - The US Sun - December 22nd, 2023
- Here's how eye exams can reveal several health conditions beyond your sight - The Record (New Westminster) - December 22nd, 2023
- At Bread for the Citys vision clinic, patients can see clearly now - The Washington Post - December 13th, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or Scam (2024) | Vashon-Maury Island Beachcomber - Vashon-Maury Island Beachcomber - December 13th, 2023
- The Benefits of Donning Prescription Sunglasses for Vision Correction and Protection - Anti Aging News - December 13th, 2023
- Vision Pro training of Apple retail store employees to start soon - BGR - December 13th, 2023
- 6 Best Vitamins and Supplements for Healthy Eyes - CNET - December 13th, 2023
- Eye Health: How to Protect Eyes From Digital Strain, Vision Loss and More? 5 Tips - India.com - December 13th, 2023
- How to watch the solar eclipse without damaging your eyesight - WATE 6 On Your Side - October 16th, 2023
- Can Optical Illusions Improve Vision? Know The Best One That Benefits Eyesight - Times Now - May 17th, 2023
- Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones - April 15th, 2023
- Revolution Medicines to Participate in 22nd Annual Needham Healthcare Conference - April 15th, 2023
- GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update - April 15th, 2023
- Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow - April 15th, 2023
- Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting - April 15th, 2023
- Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference - April 15th, 2023
- Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023 - April 15th, 2023
- Oncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological... - April 15th, 2023
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 15th, 2023
- Alvotech Provides Regulatory Update on AVT02 Biologics License Application - April 15th, 2023
- Vivoryon Therapeutics N.V. to Report Full Year 2022 Financial Results and Operational Progress on April 19, 2023 - April 15th, 2023
- Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China - April 15th, 2023
- Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting - April 15th, 2023
- QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023 - April 15th, 2023
- ITM lädt zu Symposium und Messestand auf der Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Leipzig ein - April 15th, 2023
- International Carrot Day: From healthy eyesight to weight loss - 5 wonderful benefits of carrot - Zee Business - April 7th, 2023
- How the Human Eye Works | Cornea Layers/Role | Light Rays - NKCF.org - December 11th, 2022
- Eye Emergencies: Types, Symptoms, and Prevention - Healthline - November 25th, 2022
- The criteria for certification | RNIB - November 25th, 2022
- Foresight: Eye-Net Successfully Showcases its Advanced Solution to Leading OEMs and Tier One Suppliers in Japan - Marketscreener.com - November 25th, 2022
- Can you see me now? Average person begins worrying about their vision at age 39 - Study Finds - September 29th, 2022
- Contact lens wearers at higher risk of rare eye infection are you caring for your lenses the right way? - News24 - September 29th, 2022
- A man who popped a champagne cork into his eye says it felt like being poked 'times a thousand.' His vision was saved after months of treatment but it... - September 29th, 2022
- Whitsett Vision Group First to Use Revolutionary New Lens to Dramatically Improve Patients' Eyesight - PR Newswire - September 29th, 2022
- 'As one door closes, another opens': Adelaide man turned to yoga, meditation after major vision loss - SBS - September 29th, 2022
- Stephen Curry, whose $185,000 worth vehicle almost took his life, is sure to lose his eyesight due to a genetic defect - The Sportsrush - September 29th, 2022
- NCCVEH Names Dr. Donny W. Suh, Gavin Herbert Eye Institute, UC Irvine, as Recipient of the 8th Annual Bonnie Strickland Champion for Children's Vision... - September 29th, 2022
- XP Health Raises $17.1M Series A to Transform Vision Benefits for Insurance Carriers, Companies and Employees - PR Web - September 29th, 2022
- Everything You Need To Know About Ocular Herpes Zoster: Symptoms, Treatment, And Complications - World Nation News - September 29th, 2022
- Blurry vision turned out be tumour behind Exeter woman's eye - Devon Live - April 26th, 2022
- Woman who lost half her body weight sheds the stones for second time after sight loss - Yahoo News - April 26th, 2022